ResearcherShandong UniversityActive in the last 2 years

Zhen Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8037-4245; OpenAlex author ID A5100332555. Sources: OpenAlex.

Their work

Papers: 4 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 10

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 2 papers · 2024: 1 paper

Papers 4

Microbiome and metabolome analysis in smoking and non-smoking pancreatic ductal adenocarcinoma patients. Last author DOI 10.1186/s12866-024-03688-5 ↗
Is the radiomics-clinical combined model helpful in distinguishing between pancreatic cancer and mass-forming pancreatitis? Co-author DOI 10.1016/j.ejrad.2023.110857 ↗
Editorial Comment: Dark-Blood Dual-Energy CT for Pancreatic Cancer-A New Approach for Assessment of Vascular Involvement. Co-author DOI 10.2214/ajr.22.28952 ↗
Photosensitizer IR700DX-6T- and IR700DX-mbc94-mediated photodynamic therapy markedly elicits anticancer immune responses during treatment of pancreatic cancer. Co-author DOI 10.1016/j.phrs.2021.105811 ↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Weinuo Qu · 1 shared paper, 2023 · strength 0.18
- Paper Is the radiomics-clinical combined model helpful in distinguishing between pancreatic cancer and mass-forming pancreati… DOI 10.1016/j.ejrad.2023.110857 ↗
Ihab R. Kamel · 1 shared paper, 2023 · strength 0.18
- Paper Is the radiomics-clinical combined model helpful in distinguishing between pancreatic cancer and mass-forming pancreati… DOI 10.1016/j.ejrad.2023.110857 ↗
Ruiguang Ma · 1 shared paper, 2024 · strength 0.17
- Paper Microbiome and metabolome analysis in smoking and non-smoking pancreatic ductal adenocarcinoma patients. DOI 10.1186/s12866-024-03688-5 ↗
Yiqing Zhu · 1 shared paper, 2024 · strength 0.17
- Paper Microbiome and metabolome analysis in smoking and non-smoking pancreatic ductal adenocarcinoma patients. DOI 10.1186/s12866-024-03688-5 ↗
Xiao Liang · 1 shared paper, 2024 · strength 0.17
- Paper Microbiome and metabolome analysis in smoking and non-smoking pancreatic ductal adenocarcinoma patients. DOI 10.1186/s12866-024-03688-5 ↗
Yifan Wang · 1 shared paper, 2024 · strength 0.17
- Paper Microbiome and metabolome analysis in smoking and non-smoking pancreatic ductal adenocarcinoma patients. DOI 10.1186/s12866-024-03688-5 ↗
Peng Wang · 1 shared paper, 2024 · strength 0.17
- Paper Microbiome and metabolome analysis in smoking and non-smoking pancreatic ductal adenocarcinoma patients. DOI 10.1186/s12866-024-03688-5 ↗
Xiaofeng Jiang · 1 shared paper, 2021 · strength 0.12
- Paper Photosensitizer IR700DX-6T- and IR700DX-mbc94-mediated photodynamic therapy markedly elicits anticancer immune response… DOI 10.1016/j.phrs.2021.105811 ↗
Mingfeng Bai · 1 shared paper, 2021 · strength 0.12
- Paper Photosensitizer IR700DX-6T- and IR700DX-mbc94-mediated photodynamic therapy markedly elicits anticancer immune response… DOI 10.1016/j.phrs.2021.105811 ↗
Dawei Zhang · 1 shared paper, 2021 · strength 0.12
- Paper Photosensitizer IR700DX-6T- and IR700DX-mbc94-mediated photodynamic therapy markedly elicits anticancer immune response… DOI 10.1016/j.phrs.2021.105811 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.